关于免疫抑制瘤微环境及其对质母细胞瘤免疫疗法的影响的新兴见解
Niovi Nicolaou1, Maria S Andreou1, Christiana M Neophytou2
1Tumor Microenvironment, Metastasis and Experimental Therapeutics Laboratory, Basic and Translational Cancer Research Center, Department of Life Sciences, European University Cyprus, Nicosia, Cyprus.
Frontiers in immunology
|November 10, 2025
概括
质母细胞瘤免疫疗法面临着由于瘤异质性和免疫抑制瘤微环境 (TME) 的挑战. 针对瘤和TME的创新策略对于改善质母细胞瘤治疗结果至关重要.
科学领域:
- 神经瘤学神经瘤学
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
背景情况:
- 质母细胞瘤是最常见和最致命的脑癌.
- 由于瘤异质性,血脑屏障 (BBB) 透问题,耐药性和免疫抑制性瘤微环境 (TME),传统和向疗法经常失败.
研究的目的:
- 审查关于TME在质母细胞瘤免疫疗法疗效中的作用的最新证据.
- 讨论目前在质母细胞瘤治疗中免疫疗法的挑战和机会.
主要方法:
- 对最近的研究进行了全面的文献审查.
- 对正在进行的质母细胞瘤免疫疗法临床试验的分析.
主要成果:
- 各种TME成分显著调节免疫治疗的有效性.
- 尽管面临挑战,免疫疗法仍然是有前途的.
结论:
- 了解和准TME对于推进质母细胞瘤免疫疗法至关重要.
- 需要创新策略来克服治疗失败并改善患者的治疗结果.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K


